Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Thürmann P:

Potentially inappropriate medication among people with dementia in eight European countries. Renom-Guiteras A et al. Age Ageing. (2018)

Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study. Brinkman DJ et al. Clin Pharmacol Ther. (2018)

[Polypharmacy]. Thürmann PA et al. MMW Fortschr Med. (2014)

Search results

Items: 1 to 20 of 134

1.

Multidisciplinary intervention to improve medication safety in nursing home residents: protocol of a cluster randomised controlled trial (HIOPP-3-iTBX study).

Krause O, Wiese B, Doyle IM, Kirsch C, Thürmann P, Wilm S, Sparenberg L, Stolz R, Freytag A, Bleidorn J, Junius-Walker U; HIOPP-3-iTBX study group.

BMC Geriatr. 2019 Jan 25;19(1):24. doi: 10.1186/s12877-019-1027-0.

2.

A novel superior medication-based chronic disease score predicted all-cause mortality in independent geriatric cohorts.

Quinzler R, Freitag MH, Wiese B, Beyer M, Brenner H, Dahlhaus A, Döring A, Freund T, Heier M, Knopf H, Luppa M, Prokein J, Riedel-Heller SG, Schäfer I, Scheidt-Nave C, Scherer M, Schöttker B, Szecsenyi J, Thürmann P, van den Bussche H, Gensichen J, Haefeli WE.

J Clin Epidemiol. 2019 Jan;105:112-124. doi: 10.1016/j.jclinepi.2018.09.004. Epub 2018 Sep 22.

PMID:
30253216
3.

[Drug Therapy Safety: Digital and interprofessional for and with patients].

Schubert I, Thürmann PA.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Sep;61(9):1059-1061. doi: 10.1007/s00103-018-2799-7. German. No abstract available.

PMID:
30109364
4.

[Medication safety for nursing home residents].

Jaehde U, Thürmann P.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Sep;61(9):1111-1118. doi: 10.1007/s00103-018-2796-x. Review. German.

PMID:
30083948
5.

[Simplifying complex drug therapies : Challenges and solutions].

Wurmbach VS, Lampert A, Schmidt SJ, Bernard S, Thürmann PA; HIOPP-6 Konsortium, Seidling HM, Haefeli WE.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Sep;61(9):1146-1151. doi: 10.1007/s00103-018-2790-3. Review. German.

PMID:
30066132
6.

[Standardized national medication plan : The pilot projects MetropolMediplan 2016, model region Erfurt, and PRIMA].

Dormann H, Maas R, Eickhoff C, Müller U, Schulz M, Brell D, Thürmann PA; MetropolMediplan 2016; Modellregion Erfurt; PRIMA.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Sep;61(9):1093-1102. doi: 10.1007/s00103-018-2789-9. Review. German.

PMID:
30046864
7.

Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study.

Brinkman DJ, Tichelaar J, Mokkink LB, Christiaens T, Likic R, Maciulaitis R, Costa J, Sanz EJ, Maxwell SR, Richir MC, van Agtmael MA; Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and its affiliated Network of Teachers in Pharmacotherapy (NOTIP).

Clin Pharmacol Ther. 2018 Aug;104(2):317-325. doi: 10.1002/cpt.962. Epub 2018 Jan 30.

8.

[Which factors are associated with the use of potentially inadequate medications (PIM) in the elderly? : Results from the German health interview and examination survey (DEGS1)].

Endres HG, Kaufmann-Kolle P, Knopf H, Thürmann PA.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Jan;61(1):40-51. doi: 10.1007/s00103-017-2654-2. German.

PMID:
29138901
9.

Potentially inappropriate medication among people with dementia in eight European countries.

Renom-Guiteras A, Thürmann PA, Miralles R, Klaaßen-Mielke R, Thiem U, Stephan A, Bleijlevens MHC, Jolley D, Leino-Kilpi H, Rahm Hallberg I, Saks K, Soto-Martin M, Zabalegui A, Meyer G; RightTimePlaceCare Consortium.

Age Ageing. 2018 Jan 1;47(1):68-74. doi: 10.1093/ageing/afx147.

PMID:
28985257
10.

Response to Wise et al. (Tiotropium safety in real life populations).

Schmiedl S, Thürmann P, Fischer R, Rottenkolber D, Rottenkolber M.

Br J Clin Pharmacol. 2016 Aug;82(2):564-5. doi: 10.1111/bcp.12970. Epub 2016 May 20. No abstract available.

11.

[Influence of drugs on urological diseases].

Thürmann PA.

Urologe A. 2016 Mar;55(3):401-9; quiz 410-1. doi: 10.1007/s00120-016-0040-6. Review. German.

PMID:
26908119
12.

Association between Potentially Inappropriate Medication (PIM) Use and Risk of Hospitalization in Older Adults: An Observational Study Based on Routine Data Comparing PIM Use with Use of PIM Alternatives.

Endres HG, Kaufmann-Kolle P, Steeb V, Bauer E, Böttner C, Thürmann P.

PLoS One. 2016 Feb 3;11(2):e0146811. doi: 10.1371/journal.pone.0146811. eCollection 2016.

13.

Long-term Effect of Optimized Sedation and Pain Management after Sudden Cardiac Arrest.

Abanador-Kamper N, Wolfertz J, Thürmann P, Kamper L, Seyfarth M.

Open Cardiovasc Med J. 2015 Jun 26;9:91-5. doi: 10.2174/1874192401509010091. eCollection 2015.

14.

Tiotropium Respimat(®) vs. HandiHaler(®): real-life usage and TIOSPIR trial generalizability.

Schmiedl S, Fischer R, Ibanez L, Fortuny J, Thürmann P, Ballarin E, Ferrer P, Sabaté M, Rottenkolber D, Gerlach R, Tauscher M, Reynolds R, Hasford J, Rottenkolber M.

Br J Clin Pharmacol. 2016 Feb;81(2):379-88. doi: 10.1111/bcp.12808. Epub 2015 Dec 23.

15.

The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries.

Renom-Guiteras A, Meyer G, Thürmann PA.

Eur J Clin Pharmacol. 2015 Jul;71(7):861-75. doi: 10.1007/s00228-015-1860-9. Epub 2015 May 14.

16.

Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial.

Rottenkolber M, Fischer R, Ibáñez L, Fortuny J, Reynolds R, Amelio J, Gerlach R, Tauscher M, Thürmann P, Hasford J, Schmiedl S.

BMC Pulm Med. 2015 May 6;15:55. doi: 10.1186/s12890-015-0051-x.

18.

Utilisation and off-label prescriptions of respiratory drugs in children.

Schmiedl S, Fischer R, Ibáñez L, Fortuny J, Klungel OH, Reynolds R, Gerlach R, Tauscher M, Thürmann P, Hasford J, Rottenkolber M.

PLoS One. 2014 Sep 2;9(9):e105110. doi: 10.1371/journal.pone.0105110. eCollection 2014.

19.

Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients.

Rottenkolber M, Rottenkolber D, Fischer R, Ibáñez L, Fortuny J, Ballarin E, Sabaté M, Ferrer P, Thürmann P, Hasford J, Schmiedl S.

Respir Med. 2014 Aug;108(8):1075-90. doi: 10.1016/j.rmed.2014.05.014. Epub 2014 Jun 5. Review.

20.

[Polypharmacy].

Thürmann PA.

MMW Fortschr Med. 2014 May 28;156(10):56-61; quiz 62. Review. German. No abstract available.

PMID:
24930234

Supplemental Content

Loading ...
Support Center